Dogwood Therapeutics, Inc. (DWTX)
↓ Download CSVKey ratios (FY2025)
-45.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$27.97M | -$12.23M | -$5.45M | -$12.32M | -$15.64M | -$10.01M | — |
| Net Income | -$34.26M | -$12.35M | -$5.30M | -$12.25M | -$15.96M | -$10.35M | — |
| EPS (Diluted) | $-7.13 | $-12.52 | $-7.05 | $-1.11 | $-1.92 | $-2.10 | — |
| Total Assets | $90.17M | $94.31M | $4.17M | $8.37M | $15.78M | $31.47M | — |
| Total Liabilities | $15.27M | $30.03M | $358.5K | $1.04M | $1.28M | $1.53M | — |
| Shareholders' Equity | $74.90M | -$10.12M | $3.81M | $7.33M | $14.50M | $29.94M | -$5.02M |
| Cash & Equivalents | $6.52M | $14.85M | $3.32M | $7.03M | $14.01M | $29.80M | — |
| Operating Cash Flow | -$15.62M | -$8.79M | -$4.87M | -$11.47M | -$15.69M | -$3.90M | — |
| Shares Outstanding | 29.74M | 1.33M | 770.3K | 18.33M | 8.33M | 8.31M | — |